Silver Spring, Maryland–(ENEWSPF)–July 3, 2015. The U.S. Food and Drug Administration approved the first drug for cystic fibrosis directed at treating the cause of the disease in people who have two copies of a specific mutation.
FDA Approves New Treatment for Cystic Fibrosis
More in Health and Fitness:
